for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. FDA declines to approve Akcea/Ionis genetic disease drug

Aug 27 (Reuters) - The U.S. Food and Drug Administration on Monday declined to approve a drug from Akcea Therapeutics Inc and Ionis Pharmaceuticals that aims to treat a genetic disease which causes fat accumulation in the blood.

An advisory committee to the health regulator voted 12-8 in favor of the drug in a meeting held in May. (Reporting by Aakash Jagadeesh Babu, Tamara Mathias and Ankit Ajmera in Bengaluru; Editing by Sriraj Kalluvila)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up